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ABSTRACT 
Exaggerated cardiovascular (CV) responses to exercise can lead to adverse CV events. Previous studies 
have reported that P2X3 receptors, found on the peripheral endings of afferents, contribute to an 
exaggerated exercise pressor reflex in individuals with CV-related diseases. One way to investigate the 
role played by these receptors in CV pathophysiology is through immunoblotting. The Jess (Protein 
Simple) provides an automated option for the protein separation and immunoblotting of the traditional 
Western Blot and allows for total protein staining, an improvement over the use of loading controls to 
normalize for sample loading variability. PURPOSE: The purpose of this study was to develop a protocol, 
using the Jess, for quantifying P2X3 receptor protein expression in the L4 and L5 dorsal root ganglia (DRG) 
of healthy and type 1 diabetic rats. METHODS: Streptozotocin (STZ), 50 mg/kg, or a vehicle (CTL) was 
injected i.p into fasted Sprague Dawley rats (n=7 each group). After a minimum of 3 weeks, L4 and L5 
DRG were excised, immediately placed in HBSS, and then stored at -80°C until subsequent analyses. For 
quantification, samples were lysed and protein was isolated (Macherey-Nagel) and then quantified (Qubit 
protein assay kit). For an initial Optimization Run a single test sample lysate was used; different protein 
concentrations (0.1 - 1.4 mg/ml) were tested against multiple Anti-P2X3 (Novus Biologicals) dilutions (1:25 
– 1:250). Sample lysates (3 μl) and required reagents were loaded into a microplate as per manufacturer’s 
instructions and then the microplate and capillaries were loaded into the Jess. Over 3 hours; protein 
separation, antibody incubations, washes, and detection were all performed automatically within the Jess. 
The data from that run provided the optimal protein concentration and antibody dilution that were then 
used for the Sample Run, which involved running the CTL and STZ sample lysates. For the Sample Run, 
protein normalization reagent was added to the microplate in order to normalize for sample loading 
variability using total protein staining. RESULTS: Optimization Run - A protein concentration of 1.4 
mg/ml and a dilution of 1:250 for the P2X3 antibody were found to be optimal. This determination was 
based on the combination of a low background signal from the antibody and a detectable target protein 
signal. Sample Run - We found that P2X3 receptor protein expression decreased in STZ rats compared to 
CTL rats (0.82 ± 0.09 vs 1.00 ± 0.19; n=7 both groups, p=0.03). CONCLUSION: Using the Jess, an 
automated protocol was developed that detected differences in P2X3 receptor protein expression in rats 
with and without diabetes. Advantages over the traditional Western Blot include: a run time of 3 hours, 
reduced user-associated variability thru automation, and the capability of using total protein staining to 
normalize for sample loading variability. Technological advances such as the Jess are a step towards 
addressing current rigor and reproducibility concerns.  
